Rosenblatt Initiates Coverage On Nutanix with Buy Rating, Announces Price Target of $60

Rosenblatt analyst Blair Abernethy has initiated coverage on Nutanix (NASDAQ: NTNX) with a Buy rating. The firm has set a price target of $60 for the company's stock.